{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of Benzodiazepines as Anxiolytics in Neonates: Are We There Yet?

Activity Steps


This article has been approved by the National Association for Neonatal Nurses Certification Board for Category B credit toward recertification as an NNP.

Purpose of Activity

To become familiar with the pharmacologic effects of benzodiazepines that are used for infant sedation.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the assessment of sedation in the neonate.
  2. Identify the pharmacokinetics of benzodiazepines (BZDs) in the neonate.
  3. Identify the use of benzodiazepines (BZDs) in the neonate.
Price: $24.95


  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

Test Code: ANC0314
Published: Apr 2014
Expires: 3/3/2023
Required Passing Score: 13/18 (72%)
Authors: Michelle A. Nelson, MSN, RN, NNP-BC; Wanda T. Bradshaw, MSN, RN, NNP-BC, PNP, CCRN